Analyst consensus rating
Surgery Partners Analyst Rating: Buy
Direct answer
Surgery Partners's consensus rating is Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.82.
Forecast evidence checked October 17, 2026.
Get free Surgery Partners email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.61
- Average price target
- $18.82
- High price target
- $24.00
- Low price target
- $14.00
- Low target gap
- -4.2%
- Target upside
- +28.8%
- High target gap
- +64.3%
- Target range width
- 68.4%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Surgery Partners?
Surgery Partners has a verified Buy consensus. The same dataset has an average price target of $18.82.
How far are Surgery Partners's low and high targets from the recorded price?
The low target implies -4.2%, while the high target implies +64.3%.
How many analysts are included in Surgery Partners's consensus?
The verified consensus includes 11 analysts.
How is Surgery Partners's target upside or downside calculated?
The average target of $18.82 is divided by the recorded price of $14.61, then one is subtracted to produce +28.8%. This does not guarantee a future return.
When was Surgery Partners's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.